Where we come from: Founded in May 2008 in Utah, the company draws on a legacy of high tech innovation that began with Bionic Technologies, a spin-off from the University of Utah in 1997. The company started by Brian Hatt and Prof. Richard A. Normann - also the inventor of the Utah Electrode Array – was later taken over by Cyberkinetics Neurotechnology Systems Inc (CKI). Having taken major strides in applying the technology to the human body, the research business of CKI was then acquired by Blackrock Microsystems LLC.
What we are: Blackrock is a privately held company that provides enabling tools for the neuroscience, neural engineering and neuroprosthetics research and clinical community worldwide.
Where we are heading: Professor Florian Solzbacher, President and Executive Chairman of Blackrock Microsystems, has created a commercial vision for the company to lead the market in implantable microsystems. Our team caters to the immediate and future needs of the research markets.
These existing markets together with major technical breakthroughs in chronically implantable microsystems propel us to the forefront of clinical key solutions for next generation pharma development, healthcare and personalized medicine.
Who we are looking for: Blackrock builds its business and operations on the firm belief that the best technologies are those that answer the needs of customers and are successfully commercialised out of sophisticated (academic) research and partnerships.
If you have a technology or application know-how that could contribute to our portfolio, or if you just want to know more, please contact us.